VR Logo

Supriya Pharmaceuticals Ltd.


Healthcare | Drugs & Pharma

we think vacations are for wimps

50 Stocks to buy right now

Join Value Research Stock Advisor now and be among the first to discover Stock Ideas

ajax-loader
Please wait...

ajax-loader
Please wait...

ajax-loader
Please wait...

ajax-loader
Please wait...

ajax-loader
Please wait...

Financial Year Full AR Chairman's
Speech
Director's
Report
Management
Discussion
Corporate
Governance
Auditor's
Report
Notes to
Accounts
2010 download pdf full AR
2007 download pdf full AR download pdf chairman speech download pdf director's report download pdf management discussion download pdf corporate governance download pdf auditor's report download pdf account notes
2005 download pdf full AR download pdf chairman speech download pdf director's report download pdf management discussion download pdf corporate governance download pdf auditor's report download pdf account notes
2004 download pdf full AR download pdf chairman speech download pdf director's report download pdf management discussion download pdf corporate governance download pdf auditor's report download pdf account notes
2003 download pdf full AR download pdf chairman speech download pdf director's report download pdf management discussion download pdf corporate governance download pdf auditor's report download pdf account notes
1999 download pdf full AR download pdf chairman speech download pdf director's report download pdf management discussion download pdf corporate governance download pdf auditor's report download pdf account notes
1998 download pdf full AR download pdf chairman speech download pdf director's report download pdf management discussion download pdf corporate governance download pdf auditor's report download pdf account notes

About The Company

Business: Manufacture of allopathic pharmaceutical preparations

Incorporated: 1985

Chairman: --

Managing Director: --

Group: --

Listing:

Headquarters: --

Website:--

Key Facts

Market cap: R --

Revenue (TTM): R --

Earnings (TTM): R --

: R --

: R --

Promoters' ownership: --

Liquidity:

52 Week range: R -- - --

Face value: R--

Shares outstanding: --

7 Years Aggregate:

  • CFO: 5.12 Cr
  • EBITDA: -4.28 Cr
  • Net Profit: 1.29 Cr

Stock Performance

Time Period Supriya Pharmaceuticals S&P BSE Healthcare* S&P BSE Small Cap*
YTD---3.943.68
1 month--2.737.34
3 months---4.031.47
1 Year--16.9466.63
3 Years--22.1628.15
5 Years--10.8118.83
10 Years--15.2117.28
As on *As on 18-Jan-2022